InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.380
-0.020 (-1.43%)
At close: Sep 25, 2026, 4:00 PM EDT
1.334
-0.046 (-3.30%)
After-hours: Sep 25, 2026, 7:31 PM EDT
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $9.17 million as of September 25, 2026. Its market cap has increased by 76.41% in one year.
Market Cap
9.17M
Enterprise Value
6.93M
1-Year Change
76.41%
Ranking
Category
Stock Price
$1.38
ChartMarket Cap Chart
Since May 6, 2014, InMed Pharmaceuticals's market cap has decreased from $9.40M to $9.17M, a decrease of -2.45%. That is a compound annual growth rate of -0.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 9.17M | 118.73% |
| Dec 31, 2025 | 4.19M | 22.12% |
| Dec 31, 2024 | 3.43M | 57.02% |
| Dec 29, 2023 | 2.19M | -31.94% |
| Dec 30, 2022 | 3.21M | -82.66% |
| Dec 31, 2021 | 18.52M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aytu BioPharma | 25.10M |
| TherapeuticsMD | 24.65M |
| Biofrontera | 17.82M |
| Caring Brands | 12.60M |
| Apimeds Pharmaceuticals US | 7.42M |
| Gelteq | 6.15M |
| Sonoma Pharmaceuticals | 5.96M |
| cbdMD | 5.14M |